The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren’t FDA-approved.
Please follow and like us:
TECH DEIYO
Science and Technolgy blog
Hims & Hers Super Bowl controversy: What the ad left out about its ‘alternative’ weight-loss drugs
